ClinVar Miner

Submissions for variant NM_000543.5(SMPD1):c.83C>T (p.Pro28Leu)

gnomAD frequency: 0.00001  dbSNP: rs556155962
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000728133 SCV000855667 likely benign not specified 2017-07-10 criteria provided, single submitter clinical testing
Invitae RCV000915596 SCV001060811 benign Niemann-Pick disease, type B; Niemann-Pick disease, type A 2024-01-27 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001107111 SCV001264242 uncertain significance Niemann-Pick disease, type A 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Ambry Genetics RCV003165955 SCV003911737 likely benign Inborn genetic diseases 2022-11-19 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
PreventionGenetics, part of Exact Sciences RCV003908018 SCV004719664 likely benign SMPD1-related condition 2022-03-28 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001357849 SCV001553438 uncertain significance not provided no assertion criteria provided clinical testing The SMPD1 p.Pro28Leu variant was not identified in the literature but was identified in dbSNP (ID: rs556155962) and ClinVar (classified as likely benign by EGL Genetics). The variant was identified in control databases in 143 of 275324 chromosomes (2 homozygous) at a frequency of 0.0005194 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 140 of 30476 chromosomes (freq: 0.004594), Other in 1 of 7038 chromosomes (freq: 0.000142), African in 1 of 23448 chromosomes (freq: 0.000043) and Latino in 1 of 35150 chromosomes (freq: 0.000028), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), or European (non-Finnish) populations. The p.Pro28 residue is conserved in mammals but not in more distantly related organisms however four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.
Natera, Inc. RCV001107111 SCV002091653 benign Niemann-Pick disease, type A 2017-05-08 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.